NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences on Thursday announced the acquisition of the flow cytometry business assets of ReaMetrix India for an undisclosed amount.

Beckman Coulter LS said that the deal provides it with "temperature-stable, single-dose, multicolor antibody cocktails targeting the HIV monitoring and clinical research markets." It added that ReaMetrix's products complement its flow cytometry product portfolio with reagents that streamline the sample preparation process and provide standardized reagent combinations to cytometry labs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.